Cargando…
Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels
OBJECTIVE: Quetiapine use at standard doses has been associated with hyperglycemia and dyslipidemia. However, whether even frequently prescribed low‐dose quetiapine results in significant metabolic disturbances remains unclear. Thus, this study aimed to investigate the association between off‐label,...
Autores principales: | Højlund, Mikkel, Støvring, Henrik, Andersen, Kjeld, Correll, Christoph U., Hallas, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099591/ https://www.ncbi.nlm.nih.gov/pubmed/36281759 http://dx.doi.org/10.1111/acps.13515 |
Ejemplares similares
-
Association of Low-Dose Quetiapine and Diabetes
por: Højlund, Mikkel, et al.
Publicado: (2021) -
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Who prescribes quetiapine in Denmark?
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Use of a Prescribed Ephedrine/Caffeine Combination and the Risk of Serious Cardiovascular Events: A Registry-based Case-Crossover Study
por: Hallas, Jesper, et al.
Publicado: (2008) -
Use of antipsychotics in Denmark 1997–2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses
por: Højlund, M., et al.
Publicado: (2021)